Mumtaz Khalid, Hamid Saeed, Ahmed Shahid, Moatter Tariq, Mushtaq Shamim, Khan Anis, Mizokami Masashi, Jafri Wasim
Departments of Medicine and Pathology, Aga Khan University, Karachi, Pakistan.
Hepat Mon. 2011 Jan;11(1):14-8.
Hepatitis B virus (HBV) genotypes and mutations are gaining importance in determining the clinical course of chronic liver disease.
To determine and compare the distribution of HBV genotypes and genomic variations in Pakistan to other parts of the world.
We conducted a prospective study at Aga Khan University Hospital from December 2006 to December 2008. HBV genotype was determined in 257 HBV DNA-positive patients. Patients were divided into two groups according to HBeAg positivity. Mutations in the pre-core and core promoter regions of HBV were determined in HBeAg-negative patients by line probe INNOLIPA assay.
The mean±SD age of patients was 28±5 years; there were 201 (78%) men. HBeAg was positive in 219 (85%) patients and negative in 38 (15%). HBeAg-positive patients were younger than HBeAg-negative patients (95% vs 21% in ≤30 years, p<0.001). HBV genotype D found in 247 (96.2 %) patients followed by a combined infection with HBV genotype B+D in 9 (3.3%) and 1 (0.5%) with genotype A. The mutations identified in 38 HBeAg-negative patients were T1762/A1764 in 21 (55.2%), PC mutant in 7 (18.4%), T1762/A1764/PC mutant in 2 (5%) and T1762/A1764/PC wild mutation in 1 (2%); no mutation identified in 7 (18.4%). Phylogenetic analysis did not show any significant differences between HBV genotype D isolated from Pakistan and those isolated from other parts of the world.
HBV genotype D is predominant in Pakistan, irrespective of HBeAg status. PC and BCP mutations were found in significant numbers of patients infected with genotype D. The HBV genotype D isolates from Pakistan are identical to the sequences isolated from other parts of the world.
乙型肝炎病毒(HBV)基因型和突变在决定慢性肝病的临床病程中日益重要。
确定并比较巴基斯坦与世界其他地区HBV基因型和基因组变异的分布情况。
我们于2006年12月至2008年12月在阿迦汗大学医院进行了一项前瞻性研究。对257例HBV DNA阳性患者进行了HBV基因型测定。患者根据HBeAg阳性情况分为两组。通过线性探针INNOLIPA检测法对HBeAg阴性患者的HBV前核心区和核心启动子区突变进行了测定。
患者的平均年龄±标准差为28±5岁;男性有201例(78%)。219例(85%)患者HBeAg阳性,38例(15%)患者HBeAg阴性。HBeAg阳性患者比HBeAg阴性患者年轻(≤30岁者中分别为95%对21%,p<0.001)。247例(96.2%)患者中发现HBV基因型D,9例(3.3%)患者为HBV基因型B+D合并感染,1例(0.5%)患者为基因型A。在38例HBeAg阴性患者中鉴定出的突变情况为:21例(55.2%)为T1762/A1764,7例(18.4%)为前核心区突变,2例(5%)为T1762/A1764/前核心区突变,1例(2%)为T1762/A1764/前核心区野生型突变;7例(18.4%)未发现突变。系统发育分析未显示从巴基斯坦分离的HBV基因型D与从世界其他地区分离的基因型D之间存在任何显著差异。
无论HBeAg状态如何,HBV基因型D在巴基斯坦占主导地位。在大量感染基因型D的患者中发现了前核心区和基本核心启动子区突变。从巴基斯坦分离的HBV基因型D与从世界其他地区分离的序列相同。